Vault-13

TRV GP IV, LLC

Boston, MA · CIK 1688325 · 13F filing filed 2022-08-12

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$152.1m reported value -44.3% vs Q1 2022
5positions
100.0%in top 10
0 new 0 added 0 reduced 0 sold out vs Q1 2022

Holdings, Q2 2022

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 TANGO THERAPEUTICS INC COM TNGX TNGX 19,363,975 $87.7m57.68% 57.68% UnchangedShares held: Q3 2021 19.4m, Q4 2021 19.4m, Q1 2022 19.4m, Q2 2022 19.4m
2 REVOLUTION MEDICINES INC COM RVMD RVMD 1,419,900 $27.7m18.20% 18.20% UnchangedShares held: Q3 2021 1.4m, Q4 2021 1.4m, Q1 2022 1.4m, Q2 2022 1.4m
3 PLIANT THERAPEUTICS INC COM PLRX PLRX 2,132,867 $17.1m11.23% 11.23% UnchangedShares held: Q3 2021 2.1m, Q4 2021 2.1m, Q1 2022 2.1m, Q2 2022 2.1m
4 FULCRUM THERAPEUTICS INC COM FULC FULC 2,343,154 $11.5m7.55% 7.55% UnchangedShares held: Q3 2021 2.3m, Q4 2021 2.3m, Q1 2022 2.3m, Q2 2022 2.3m
5 MAGENTA THERAPEUTICS INC COM COM 6,758,204 $8.1m5.33% 5.33% UnchangedShares held: Q3 2021 6.8m, Q4 2021 6.8m, Q1 2022 6.8m, Q2 2022 6.8m